107 related articles for article (PubMed ID: 6323626)
21. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
[TBL] [Abstract][Full Text] [Related]
22. Leukotriene B4 activates T cells that inhibit B-cell proliferation in EBV-infected cord blood-derived mononuclear cell cultures.
Liu A; Claesson HE; Mahshid Y; Klein G; Klein E
Blood; 2008 Mar; 111(5):2693-703. PubMed ID: 18094330
[TBL] [Abstract][Full Text] [Related]
23. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis.
Cunningham AL; Nelson PA; Fathman CG; Merigan TC
J Gen Virol; 1985 Feb; 66 ( Pt 2)():249-58. PubMed ID: 2981967
[TBL] [Abstract][Full Text] [Related]
24. Secretion of gamma-interferon at the cellular level. Induction by Epstein-Barr virus.
Andersson U; Martinez-Maza O; Andersson J; Britton S; Gadler H; De Ley M; Modrow S
Scand J Immunol; 1984 Nov; 20(5):425-32. PubMed ID: 6095439
[TBL] [Abstract][Full Text] [Related]
25. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells.
Iwata S; Saito T; Ito Y; Kamakura M; Gotoh K; Kawada J; Nishiyama Y; Kimura H
Cancer Sci; 2012 Feb; 103(2):375-81. PubMed ID: 22017376
[TBL] [Abstract][Full Text] [Related]
27. Human T-cell leukemia/lymphoma virus I and/or Epstein-Barr virus-infected B-cell lines spontaneously produce acid-labile alpha-interferon.
Boumpas DT; Hooks JJ; Popovic M; Tsokos GC; Mann DL
J Clin Immunol; 1985 Sep; 5(5):340-4. PubMed ID: 2997264
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.
Clave E; Agbalika F; Bajzik V; Peffault de Latour R; Trillard M; Rabian C; Scieux C; Devergie A; Socié G; Ribaud P; Adès L; Ferry C; Gluckman E; Charron D; Esperou H; Toubert A; Moins-Teisserenc H
Transplantation; 2004 Jan; 77(1):76-84. PubMed ID: 14724439
[TBL] [Abstract][Full Text] [Related]
29. Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus.
Manor D; Margalith M
Cancer Biochem Biophys; 1979; 3(4):157-62. PubMed ID: 233303
[TBL] [Abstract][Full Text] [Related]
30. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
Tosato G; Magrath IT; Blaese RM
J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
[TBL] [Abstract][Full Text] [Related]
31. Interferons on the transformation of non-T blood mononuclear leukocytes by Epstein--Barr virus.
Chang RS
J Interferon Res; 1984; 4(2):173-7. PubMed ID: 6086777
[TBL] [Abstract][Full Text] [Related]
32. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
[TBL] [Abstract][Full Text] [Related]
33. Acid labile type alpha interferon induction by formalinized Staphylococcus aureus (Cowan I) in human mononuclear leukocytes.
Gore MM; Kedarnath N; Banerjea AC; Ranbhor SV; Ghosh SN
Indian J Med Res; 1983 Jun; 77():770-6. PubMed ID: 6605916
[No Abstract] [Full Text] [Related]
34. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
36. Effects of recombinant human interferons on rheumatoid arthritis B lymphocytes activated by Epstein-Barr virus.
Lotz M; Tsoukas CD; Curd JG; Carson DA; Vaughan JH
J Rheumatol; 1987 Feb; 14(1):42-5. PubMed ID: 3033238
[TBL] [Abstract][Full Text] [Related]
37. [Change and effect of Epstein Barr virus (EBV) antigen induced T8 cells in nasopharyngeal carcinoma patients and EBV seropositive individuals].
Huang PC
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):12-6. PubMed ID: 8392927
[TBL] [Abstract][Full Text] [Related]
38. Immunologic properties of Epstein-Barr virus-seronegative adults.
Jabs WJ; Wagner HJ; Neustock P; Klüter H; Kirchner H
J Infect Dis; 1996 May; 173(5):1248-51. PubMed ID: 8627079
[TBL] [Abstract][Full Text] [Related]
39. Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strain.
Häupl T; Burmester GR; Hahn G; Feige U; Rordorf-Adam C; Kalden JR
Rheumatol Int; 1989; 9(3-5):153-60. PubMed ID: 2558410
[TBL] [Abstract][Full Text] [Related]
40. Synergistic inhibition of Epstein-Barr virus: transformation of B lymphocytes by alpha and gamma interferon and by 3'-azido-3'-deoxythymidine.
Lin JC; Zhang ZX; Chou TC; Sim I; Pagano JS
J Infect Dis; 1989 Feb; 159(2):248-54. PubMed ID: 2536780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
